Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 Diabetes
Phase 1
Completed
- Conditions
- Type 2 Diabetes
- Interventions
- Drug: Oral insulinDrug: regular human insulin
- First Posted Date
- 2009-09-23
- Last Posted Date
- 2009-09-23
- Lead Sponsor
- Profil Institut für Stoffwechselforschung GmbH
- Target Recruit Count
- 10
- Registration Number
- NCT00982254
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
DIATOR-Diabetes Intervention With Atorvastatin
Phase 1
Terminated
- Conditions
- Type 1 Diabetes
- Interventions
- First Posted Date
- 2009-09-10
- Last Posted Date
- 2017-06-19
- Lead Sponsor
- Profil Institut für Stoffwechselforschung GmbH
- Target Recruit Count
- 63
- Registration Number
- NCT00974740
- Locations
- 🇩🇪
Helios Klinikum Emil von Behring, Berlin, Germany
🇩🇪Praxis Dr. Gerhard Willms, Leverkusen, Germany
🇩🇪Praxisklinik Leipzig, Leipzig, Germany
Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes
Phase 1
Completed
- Conditions
- Type 2 Diabetes
- Interventions
- Drug: insulin glargine + exenatide + preexisting metforminDrug: insulin glargine + sitagliptin + preexisting metforminDrug: insulin glargine + preexisting metformin
- First Posted Date
- 2009-09-04
- Last Posted Date
- 2009-09-04
- Lead Sponsor
- Profil Institut für Stoffwechselforschung GmbH
- Target Recruit Count
- 48
- Registration Number
- NCT00971659
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
Expanded PK and PD of Insulin Glulisine Versus Insulin Aspart in Healthy Volunteers
Phase 1
Completed
- Conditions
- Diabetes
- Interventions
- Drug: insulin aspart, insulin glulisineDrug: insulin glulisine, insulin aspart
- First Posted Date
- 2009-09-01
- Last Posted Date
- 2009-09-02
- Lead Sponsor
- Profil Institut für Stoffwechselforschung GmbH
- Target Recruit Count
- 12
- Registration Number
- NCT00969592
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
Metabolic Effect of Insulin Aspart and Human Insulin in Different Doses
Phase 1
Completed
- Conditions
- Diabetes Mellitus
- Interventions
- Drug: human regular insulin
- First Posted Date
- 2007-08-09
- Last Posted Date
- 2007-08-09
- Lead Sponsor
- Profil Institut für Stoffwechselforschung GmbH
- Target Recruit Count
- 16
- Registration Number
- NCT00513643
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
© Copyright 2025. All Rights Reserved by MedPath